Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kaptin, actin binding protein (KPTN) is a conserved cytoskeletal protein that binds to actin, a core component of the cellular cytoskeleton. It regulates actin filament dynamics, which are crucial for processes such as cellular motility and the development and maintenance of neuronal structures. KPTN mutations are associated with a rare neurodevelopmental disorder (KPTN-related disorder) that includes macrocephaly, intellectual disability, and autism-like features. Kaptin is not a traditional drug target (such as receptor or enzyme), but its dysfunction implicates cytoskeletal regulation in brain development and function. No drugs are currently known to interact directly with kaptin, and it is not classified as a canonical therapeutic target like kinases, GPCRs, or receptors. Its biological relevance is primarily in basic cell biology and rare genetic disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kaptin, actin binding protein (KPTN).